HK16086A - A 1,4-dihydropyridine derivate its preparation and pharmaceutical compositions containing it - Google Patents

A 1,4-dihydropyridine derivate its preparation and pharmaceutical compositions containing it

Info

Publication number
HK16086A
HK16086A HK160/86A HK16086A HK16086A HK 16086 A HK16086 A HK 16086A HK 160/86 A HK160/86 A HK 160/86A HK 16086 A HK16086 A HK 16086A HK 16086 A HK16086 A HK 16086A
Authority
HK
Hong Kong
Prior art keywords
derivate
dihydropyridine
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
HK160/86A
Other languages
English (en)
Inventor
Peter Neumann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of HK16086A publication Critical patent/HK16086A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HK160/86A 1978-12-18 1986-03-06 A 1,4-dihydropyridine derivate its preparation and pharmaceutical compositions containing it HK16086A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1283578A CH639659A5 (de) 1978-12-18 1978-12-18 Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.

Publications (1)

Publication Number Publication Date
HK16086A true HK16086A (en) 1986-03-14

Family

ID=4386824

Family Applications (1)

Application Number Title Priority Date Filing Date
HK160/86A HK16086A (en) 1978-12-18 1986-03-06 A 1,4-dihydropyridine derivate its preparation and pharmaceutical compositions containing it

Country Status (18)

Country Link
JP (1) JPS5583783A (fi)
AU (1) AU536055B2 (fi)
BE (1) BE880591A (fi)
CH (1) CH639659A5 (fi)
CY (1) CY1321A (fi)
DE (1) DE2949491A1 (fi)
FR (1) FR2444681A1 (fi)
GB (2) GB2103203B (fi)
HK (1) HK16086A (fi)
IE (1) IE49496B1 (fi)
IT (1) IT1164097B (fi)
KE (1) KE3593A (fi)
MY (1) MY8500130A (fi)
NL (2) NL193066C (fi)
NZ (1) NZ192422A (fi)
SE (1) SE445219B (fi)
SG (1) SG97585G (fi)
ZA (1) ZA796842B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
CH655658B (fi) * 1980-09-18 1986-05-15
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
FR2528431B1 (fr) * 1982-06-15 1986-01-10 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
IL68975A (en) * 1982-06-15 1987-01-30 Sandoz Ag 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylic acid ester derivatives in optically active form,their preparation and pharmaceutical compositions containing them
JPS5978186A (ja) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd 1,4−ジヒドロピリジン−3,5−ジカルボン酸エステル誘導体
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
HU198844B (en) * 1984-06-14 1989-12-28 Sandoz Ag Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
GB8626217D0 (en) * 1986-11-03 1986-12-03 Sandoz Ltd Pharmaceutical compositions
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
KR940003492B1 (ko) * 1988-10-27 1994-04-23 주식회사 유한양행 1,4-디하이드로피리딘유도체 및 그의 제조방법
DE4222770A1 (de) * 1992-07-10 1994-01-13 Bayer Ag Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
WO2005023787A1 (en) * 2003-09-10 2005-03-17 Shasun Chemicals And Drugs Limited Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
CN103613584B (zh) * 2013-11-27 2016-04-27 沈阳药科大学 一种伊拉地平合成产物后处理的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2616991A1 (de) * 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5373327A (en) * 1976-12-13 1978-06-29 Matsushita Electric Ind Co Ltd Power source system
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater

Also Published As

Publication number Publication date
IE49496B1 (en) 1985-10-16
AU5389679A (en) 1980-06-26
IT7951095A0 (it) 1979-12-14
GB2103203A (en) 1983-02-16
IT1164097B (it) 1987-04-08
GB2037766A (en) 1980-07-16
JPS5583783A (en) 1980-06-24
CH639659A5 (de) 1983-11-30
SG97585G (en) 1986-07-18
NZ192422A (en) 1982-09-14
ZA796842B (en) 1981-07-29
DE2949491A1 (de) 1980-06-26
FR2444681B1 (fi) 1982-10-29
NL7909024A (nl) 1980-06-20
NL193066C (nl) 1998-09-08
SE445219B (sv) 1986-06-09
BE880591A (fr) 1980-06-13
DE2949491C2 (fi) 1988-10-27
CY1321A (en) 1986-06-27
GB2103203B (en) 1983-06-08
GB2037766B (en) 1983-02-16
SE7910188L (sv) 1980-06-19
KE3593A (en) 1986-02-07
NL193066B (nl) 1998-05-06
FR2444681A1 (fr) 1980-07-18
NL990014I1 (nl) 1999-07-01
JPH0369910B2 (fi) 1991-11-05
MY8500130A (en) 1985-12-31
AU536055B2 (en) 1984-04-19
IE792445L (en) 1980-06-18

Similar Documents

Publication Publication Date Title
ZA791732B (en) Carbazolyl-(4)-oxypropanolamine derivatives,preparation thereof and pharmaceutical compositions containing these compounds
IL58123A (en) 4,5-diaryl-2-nitroimidazoles,their preparation and pharmaceutical compositions containing them
IL57030A0 (en) Pharmaceutical compositions containing a certain 1,4-dihydropyridine derivative
IL56992A (en) N-heterocyclyl-4-piperidinamines,their preparation and pharmaceutical compositions containing them
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
HK16086A (en) A 1,4-dihydropyridine derivate its preparation and pharmaceutical compositions containing it
IL53639A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
NZ187617A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
DE2965287D1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
IL57213A (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
IL54358A (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
IL56686A0 (en) Acylaminoalkyl-syanoguanidines,their preparation and pharmaceutical compositions containing them
IL57891A0 (en) Alkylthiophenoxyalkylamines,their preparation and pharmaceutical compositions containing them
IL57720A0 (en) Phenylpiperidine derivatives,their preparation and pharmaceutical compositions containing them
IL57754A0 (en) Benzopyranotriazoles,their preparation and pharmaceutical compositions containing them
IL56728A (en) Androstadienes,their preparation and pharmaceutical compositions containing them
IL56457A (en) 1,10'a beta-dimethyl-9,10-dihydroergocristine,its preparation and pharmaceutical compositions containing it
NZ190278A (en) 6,7-benzomorphan derivatives and pharmaceutical compositions
IL57196A (en) 1,6-dimesyl-3,4-dimethyl-d-mannitol,its preparation and pharmaceutical compositions containing it
GB2024818B (en) Phenathrenederivatives, their preparation and pharmaceutical compositions containing them
IL54001A0 (en) 2,4-dichlorophenyl-imidazolyl-ethan-ones and -ols, their preparation and pharmaceutical compositions containing the
ZA83959B (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PE Patent expired